Screener
Praxis Precision Medicines, Inc. PRAX Business Segments — Depreciation expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Depreciation.
The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001689548-26-000083
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Elsunersen | 8,141 | 1,317 | 11,338 | 2,078 |
| Other early stage assets | 5,471 | 1,417 | 8,713 | 2,522 |
| Personnel-related expenses | 18,943 | 11,913 | 36,673 | 24,943 |
| Stock-based compensation expense | 11,309 | 7,770 | 28,421 | 16,556 |
| Depreciation expense | 33 | 46 | 72 | 93 |
| Other segment expenses(a) | 12,851 | 6,753 | 24,940 | 15,129 |
| Other income, net | 13,184 | 4,940 | 26,483 | 10,372 |
| Consolidated net loss | $(83,720) | $(71,127) | $(176,281) | $(140,423) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Praxis Precision Medicines, Inc.'s business segments — depreciation expense?
- Praxis Precision Medicines, Inc. (PRAX) reported business segments — depreciation expense of $33K in Q2 2026.
- How has Praxis Precision Medicines, Inc.'s business segments — depreciation expense changed year-over-year?
- Praxis Precision Medicines, Inc.'s business segments — depreciation expense decreased by 28.3% year-over-year, from $46K to $33K.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s business segments — depreciation expense?
- Over 2 years (2023 to 2025), Praxis Precision Medicines, Inc.'s business segments — depreciation expense has grown at a -43.1% compound annual growth rate (CAGR), from $432K to $140K.
- What does business segments — depreciation expense mean?
- This metric represents the systematic allocation of the cost of tangible assets over their useful lives within the business segment. It reflects the wear and tear or obsolescence of laboratory equipment and infrastructure used in clinical research. It is a non-cash expense that impacts the segment's reported operating results.
Ask your AI about Praxis Precision Medicines, Inc.'s business segments — depreciation expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude